Wednesday, 20 Nov 2019

You are here

ACR/AAHKS Guidelines on Perioperative Management

By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow ( is prohibited.

Rheumatologists' Comments

This may be a bizarre question, but, what exactly is meant by holding a biolgic for one dosing schedule? e.g. If someone receives infliximab Q8 weeks do you give at the end of the 8 weeks or wait an additional 8 weeks then administer - in either scenario, what if that same drug is administered Q4-6 weeks?